Antikoagulation Aktuell - Prof. Dr. med. Jörg Braun

Literatur: Bridging

Als Hinweis auf potentielle weitere Informationsquellen. Kein Anspruch auf Vollständigkeit.

1. Ralf Eisele, Nima Melzer, Cornelia Englert, Peter Bramlage, Michael Spannagl. Bridging mit dem niedermolekularen Heparin Certoparin bei Patienten, bei denen eine vorübergehende Unterbrechung der oralen Antikoagulation erforderlich ist – die nicht-interventionelle, retrospektive REMEMBER-Studie. Thrombosis Research 2012. [PDF]

2. Bauersachs, Rupert M.; Schellong, Sebastian; Haas, Sylvia; Gogarten, Wiebke; Riess, Hanno; Omran, Heyder. Überbrückung der oralen Antikoagulation bei interventionellen Eingriffen. Dtsch Arztebl 2007; 104(18): A-1237 / B-1101 / C-1053 [PDF]

3. Jack Hirsh, MD, FCCP, Chair, Gordon Guyatt, MD, FCCP, Gregory W. Albers, MD, Robert Harrington, MD, FCCP, and Holger J. Schünemann, MD, PhD. Executive Summary: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133;71S-109S. [PubMed 18574259]

4. H.M. Hoffmeister, C. Bode, H. Darius, K. Huber, K. Rybak, S. Silber. Unterbrechung antithrombotischer Behandlung (Bridging) bei kardialen Erkrankungen. Kardiologe 2010; 4:365–374 [PDF]
5. Douketis JD, Johnson JA, Turpie AG: Low-molecular-weight-heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Arch Intern Med 2004; 164:1319–26. [PubMed 15226166]
6. Jafri SM: Periprocedural thromboprophylaxis in patients receiving chronic anticoagulation therapy. Am Heart J 2004; 147: 3–15. [PubMed 14691412]
7. Spandorfer J: The management of anticoagulation before and after procedures. Med Clin North Am 2001; 85: 1109–16. [PubMed 14691412]
8. Omran H, Hammerstingl C, Schmidt H, von der Recke G, Paar WD, Luderitz B: A prospective and randomized comparison of the safety and effects of therapeutic levels of enoxaparin versus unfractionated heparin in chronically anticoagulated patients undergoing elective cardiac catheterization. Thromb Haemost 2003; 90: 267–71. [PubMed 12888874]
9. Dunn AS, Turpie AG: Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med 2003; 163: 901–8. [PubMed 12719198]
10. Mehra P, Cottrell DA, Bestgen SC, Booth DF: Management of heparin therapy in the high-risk, chronically anticoagulated, oral surgery patient: a review and a proposed nomogram. J Oral Maxillofac Surg 2000; 58: 198–202. [PubMed 10670599]
11. Gerson LB, Gage BF, Owens DK, Triadafilopoulos G: Effect and outcomes of the ASGE guidelines on the periendoscopic management of patients who take anticoagulants. Am J Gastroenterol 2000; 95: 1717–24. [PubMed 10925974]
12. Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB: An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999; 81: 2–10. [PubMed 9973048]
13. Wahl MJ: Dental surgery in anticoagulated patients. Arch Intern Med 1998; 158: 1610–6. [PubMed 9701094]
14. Montalescot G, Polle V, Collet JP et al.: Low molecular weight heparin after mechanical heart valve replacement. Circulation 2000; 101: 1083–6. [PubMed 10715251]
15. Stellbrink C, Nixdorff U, Hofmann T et al.: Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial. Circulation 2004; 109: 997–1003. [PubMed 14967716]
16. Fanikos J, Tsilimingras K, Kucher N, Rosen AB, Hieblinger MD, Goldhaber SZ: Comparison of efficacy, safety, and cost of low-molecular-weight heparin with continuous-infusion unfractionated heparin for initiation of anticoagulation after mechanical prosthetic valve implantation. Am J Cardiol 2004; 93: 247–50. [PubMed 14715362]
17. Halbritter KM, Wawer A, Beyer J, Oettler W, Schellong SM: Bridging anticoagulation for patients on long-term vitamin-K-antagonists. A prospective 1 year registry of 311 episodes. J Thromb Haemost 2005; 3: 2823–5. [PubMed 16359528]
18. Spyropoulos AC, Turpie AG, Dunn AS, Kaatz S et al. Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry). J Am Coll Cardiol 2008 Oct 1;102(7):883-9. [PubMed 18805116]
19. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E: The pharmacology and management of the vitamin-K-antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 204–33. [PubMed 15383473]
20. Kearon C, Hirsh J: Management of anticoagulation before and after elective surgery. N Engl J Med 1997; 336: 1506–11. [PubMed 9154771]
21. Kearon C: Long-term management of patients after venous thromboembolism. Circulation 2004; 110: 10–8. [PubMed 15339876]
22. Katholi RE, Nolan SP, McGuire LB: The management of anticoagulation during noncardiac operations in patients with prosthetic heart valves. A prospective study. Am Heart J 1978; 96: 163–5. [PubMed 676976]
23. Spandorfer JM, Lynch S, Weitz HH, Fertel S, Merli GJ: Use of enoxaparin for the chronically anticoagulated patient before and after procedures. Am J Cardiol 1999; 84: 478–80. [PubMed 10468095]
24. Johnson JA, Turpie AG: Temporary discontinuation of oral anticoagulants: role of low-molecular-weight heparin. Thromb Haemost 2001; 85: 2323.
25. Ferreira I, Dos L, Tornos P, Nicolau I, Permanyer-Miralda G, Soler-Soler J: Experience with enoxaparin in patients with mechanical heart valves who must withhold acenocumarol. Heart 2003; 89: 527–30. [PubMed 12695457]
26. Omran H, Hammerstingl C, Schmidt H, Lüderitz B: Periinterventionelles Management bei oral antikoagulierten Patienten [Abstract L6]. Hämostaseologie 2005; 25(1): 1–54.
27. Dunn A, Spyropoulos A, Sirko S, Turpie A: Perioperative bridging therapy with enoxaparin in patients requiring interruption of long term anticoagulant therapy: a multicentre cohort study. Blood 2004; 104(abstract) 1761.
28. Hammerstingl C, Schlang G, Bernhardt P, Schmidt H, Omran H: Einsetzbarkeit niedermolekularer Heparine bei Umstellung einer oralen Antikoagulation vor Interventionen mit erhöhtem Blutungsrisiko: Das „Bonn-Register“ – Erfahrungen mit 200 Patienten. Z Kardiol 2004; 93(Suppl): 281–2.
29. Kovacs MJ, Kearon C, Rodger M et al.: Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation 2004; 110: 1658–63. [PubMed 15364803]

top |